Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients

NCT02993302 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Graves Disease

Interventions

DRUG: 1α-D3
DRUG: Placebos

Sponsor

Dr Cipto Mangunkusumo General Hospital

Collaborators

[object Object]